Instituto Hemomed Oncologia e Hematologia

São Paulo 01236-030

1 studies enrolling now · 2 studies all time

What they study most

Extensive Stage Small Cell Lung Cancer (ES-SCLC), Locally Advanced or Unresectable Metastatic Breast Cancer, Stage IV Breast Cancer

Studies at this site

• Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer — Recruiting now
• Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Metastatic Breast Cancer Who Have Received Endocrine Therapy — Running, not enrolling